Note: Ingredients listed on restricted chemical lists
EC/CAS
111-42-2
Name of the chemical
N,N-Diethanolamine (Ethanol, 2,2'-iminobis-)
Concentration
4.00%
General Information
Revision date
2018-08-27
Product name
Alinity c Lactate Dehydrogenase Reagent 1
1.2.1 Relevant identified uses
For In Vitro Diagnostic Use
Emergency telephone
Contact the CHEMTREC® Emergency Call Center for assistance with transportation or hazardous materials
Icons in SDS
Company Information
company name
Abbott Diagnostics
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H318, H351, H373
Hazard statements
Code
Statements
H318
Causes serious eye damage
Section 2
2.1 Classification of the substance or mixture
Eye Dam. 1 H318 Causes serious eye damage. Carc. 2 H351 Suspected of causing cancer. STOT RE 2 H373 May cause damage to organs through prolonged or repeated exposure.
2.2 Label elements
The product is labelled according to the Globally Harmonized System (GHS)
Signal word
Danger
Hazardous Ingredients
diethanolamine Sodium azide
Hazard statements
H318 Causes serious eye damage. H351 Suspected of causing cancer. H373 May cause damage to organs through prolonged or repeated exposure.
Precautionary statements
P201 Obtain special instructions before use. P260 Do not breathe mist / vapors / spray. Product name: Alinity c Lactate Dehydrogenase Reagent 1 P280 Wear protective gloves/protective clothing/eye protection. P305+P351+P338 If in eyes: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P310 Immediately call a poison center/doctor. P308+P313 IF exposed or concerned: Get medical advice/attention. P501 Dispose of contents / container in accordance with local regulations.
Principle Routes of Exposure
Eye Skin · Hazard Overview · Health: May cause irreversible eye damage. · Fire: Noncombustible · Reactivity: Minimal hazard - Stable, even in a fire. Not reactive with water. Not an oxidizer. · IARC (International Agency for Research on Cancer) Group 3 · Interpretation of the IARC listing Group 3: The substance or mixture listed above is not classifiable as to carcinogenicity in humans. Evidence of carcinogenicity is inadequate in humans and inadequate or limited in experimental animals.
